摘要
Long non-coding RNAs (lncRNAs) exhibit a length more than 200 nucleotides and they are characterized by non-coding RNAs (ncRNA) not encoded into proteins. Over the past few years, the role and development of lncRNAs have aroused the rising attention of re-searchers. To be specific, KCNQ1OT1, the KCNQ1 opposite strand/antisense transcript 1, is clearly classified as a regulatory ncRNA. KCNQ1OT1 is capable of interacting with miRNAs, RNAs and proteins, thereby affecting gene expression and various cell functions (e.g., cell prolifer-ation, migration, epithelial-mesenchymal transition (EMT), apoptosis, viability, autophagy and inflammation). KCNQ1OT1 is dysregulated in a wide range of human diseases (e.g., cardio-vascular disease, cancer, diabetes, osteoarthritis, osteoporosis and cataract), and it is specu-lated to act as a therapeutic target for treating various human diseases. On the whole, this review aims to explore the biological functions, underlying mechanisms and pathogenic roles of KCNQ1OT1 in human diseases.Copy
学科与关键词
- Biological role of long non-coding RNA KCNQ1OT1 in cancer progressionZhan, Kai; Pan, Huafeng; Zhou, Zhang; Tang, Wenqian; Ye, Zhining; Huang, Shaogang; Luo, Lei*Biomedicine and Pharmacotherapy, 2023, 169: 115876.
- KCNQ1OT1在肿瘤中的表达及意义胡增涛; 徐书婉; 夏浩明; 高泽玮; 黄荣菊; 唐恩雨; 姜兴明实用药物与临床, 2019, (11): 1226-1229.
- LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149Cheng, Ji-Lun; Li, Du-Juan; Lv, Ming-Yang; Pei, Yi-Jin; Zhang, Xiu-Juan; Li, Lin; Liu, Xiang-Yu; Fan, Ai-Hui*Cancer Gene Therapy, 2021, 28(7-8): 850-863.被引 15
